The stock market indices may have ended the short-term uptrend, which they were in for a couple of weeks. The day started with a smack to the downside in a pretty nasty slide, with the indices breaking early on and sliding all morning, stabilizing midday, and trying to rally late in the day. Only a pullback at the end of the day kept them from a bigger rally.

Net on the day, the Dow was down 179.85 at 17,730.48. The S&P 500 was down 20.62 to 2078.58. The Nasdaq 100 was down 51.72 to 4655.52.

Advance-declines were 4 to 1 negative on New York Stock Exchange and 2 1/2 to 1 negative on Nasdaq. Up/down volume was 4 to 1 negative on New York, with total volume of 3 3/4 billion shares. Nasdaq traded 1 3/4 billion shares, and had nearly a 3 to 1 negative volume ratio.

TheTechTrader.com board was mostly lower, except for the biotech group that had a great day today. Priceline Inc. (PCLN) really put the kabash on the Nasdaq 100 on a poor earnings report, down 138.75 to 1311.15, Google Inc. (GOOG) down 8.87 to 724.89, Apple Inc. (AAPL) down just 49 cents to 120.57, Amazon.com Inc. (AMZN) 3.88 to 655.49, and Netflix, Inc. (NFLX) 4.20 to 109.86.

Tesla Motors, Inc. (TSLA) lost 7.03 to 225.33.

In addition, Twitter, Inc. (TWTR) was down 1.19 to 27.09, Facebook, Inc. (FB) down just 61 cents to 106.49, Mobileye N.V. (MBLY) down 1.93 to 44.82, First Solar, Inc. (FSLR) 1.28 to 58.39, CyberArk Software, Ltd. (CYBR) in a weak cyber-security group, 2.45 to 44.78, and Cellectis S.A. (CLLS) 2.13 to 40.01.

On the upside, Heron Therapeutics, Inc. (HRTX) was up 1.61 to 28.09, Juno Therapeutics Inc. (JUNO) up 2.21 to 51.90, NewLink Genetics Corporation (NLNK) up 1.56 to 35.48, Weight Watchers International, Inc. (WTW) up 81 cents to 23.70, as it continues the recent rally.

Checking the TheTechTrader.com percent-gain leaderboard, Loxo Oncology, Inc. (LOXO) ran 4.43 to 27.68, or 19%, on nearly a million shares. Cytokinetics, Incorporated (CYTK) gained 1.47 to 12.29, or 14%, on 1.9 million shares. Celldex Therapeutics, Inc. (CLDX) stair-stepped its way up 1.69 to 15.46, or 12%, on 3.6 million shares. Isis Pharmaceuticals, Inc. (ISIS) thrust 6.90

Other gainers of note included Horizon Pharma (HZNP), up 1.29 to 22.29, along with many, many other biotech's today.

Stepping back and reviewing the hourly chart patterns, the indices were down from the get-go, gapping lower, bouncing, but then rolling hard all morning, until just before noon when they reached their lows for the day. They bounced midday, stabilized for a couple hours, and then tried a late rally that looked really good, until the last ten minutes when they backed off again.

Unfortunately, it was a very negative way to start the week, and potentially a back-breaker for our recent rally. Key support for Nasdaq 100 beneath here is at 4625 and 4600, and for the S&P 500 at 2060, followed by 2040.

Let's see how it goes tomorrow.

Good Trading!

In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.

Recommended Content


Recommended Content

Editors’ Picks

US economy grows at an annual rate of 1.6% in Q1 – LIVE

US economy grows at an annual rate of 1.6% in Q1 – LIVE

The US' real GDP expanded at an annual rate of 1.6% in the first quarter, the US Bureau of Economic Analysis' first estimate showed on Thursday. This reading came in worse than the market expectation for a growth of 2.5%.

FOLLOW US LIVE

EUR/USD holds gains above 1.0700, as key US data loom

EUR/USD holds gains above 1.0700, as key US data loom

EUR/USD holds gains above 1.0700 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data. 

EUR/USD News

GBP/USD extends recovery above 1.2500, awaits US GDP data

GBP/USD extends recovery above 1.2500, awaits US GDP data

GBP/USD is catching a fresh bid wave, rising above 1.2500 in European trading on Thursday. The US Dollar resumes its corrective downside, as traders resort to repositioning ahead of the high-impact US advance GDP data for the first quarter. 

GBP/USD News

Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP

Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP

Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited. 

Gold News

XRP extends its decline, crypto experts comment on Ripple stablecoin and benefits for XRP Ledger

XRP extends its decline, crypto experts comment on Ripple stablecoin and benefits for XRP Ledger

Ripple extends decline to $0.52 on Thursday, wipes out weekly gains. Crypto expert asks Ripple CTO how the stablecoin will benefit the XRP Ledger and native token XRP. 

Read more

Majors

Cryptocurrencies

Signatures